authors
- Heng, Daniel Yick Chin
- Doshi, Gury K
- Dutailly, Pascale
- Houchard, Aude
- Lothgren, Mickael
- Monnette, Alisha
- Wang, Yunfei
- Perrot, Valerie
- Lalani, Aly-Khan
Real-world outcomes among patients with advanced/metastatic renal cell carcinoma (mRCC) treated with cabozantinib or other tyrosine kinase inhibitors (TKIs) after checkpoint inhibitor (CPI) therapy.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2023
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal